512600 — Astal Laboratories Share News
0.000.00%
- IN₹2.79bn
- IN₹3.29bn
- IN₹2.50bn
Brief: Astal Laboratories Signed Letter Of Intent With Immuna Therapeutics GMBH
India's Astal Laboratories gains after securing European Union export compliance
Brief: Astal Laboratories To Buy 100% Of Sriven Pharmachem
Brief: Astal Laboratories Buys Pharmaceutical Intermediates Manufacturing Plant Of Shree Venus Health Sciences
Brief: Macro International Approved Raising Of Funds
Brief: Macro International To Consider Issue Of Shares On Preferential Basis
Brief: Macro International Ventures Into Contrast Media Business, Introduces Lopromide Usp For Bulk Drug Manufacturing
Brief: Macro International Says Kommera Harish Resigns As Chief Executive Officer
Brief: Macro International Says Sesha Sai Nikhil Chintalapati Resigns As CFO
Brief: Macro International Names Kommera Harish As CEO
Brief: Macro International Says MD Sudhir Kumar Parasrampuria Resigns
Brief: Macro International Re-Appoints Sudhir Kumar Parasrampuria As MD